The words “you have cancer” are life-changing for everyone impacted by a new diagnosis. AbbVie understands this, and that is why we have joined forces with leading global patient advocates to increase awareness about blood cancers.

On June 24, 2022, AbbVie shared findings from the newly launched Emotional Impact Report, a survey of more than 300 chronic lymphocytic leukemia (CLL) patients, caregivers and healthcare providers (HCPs) in the U.S., which uncovered insights about the emotional journey associated with a CLL diagnosis.

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

AbbVie is donating $35 million to help support underserved communities and healthcare systems working to address the impact of the COVID-19 global pandemic.

On March 21, 2019, AbbVie announced a $40 million donation to rebuild Neal Math & Science Academy, North Chicago’s only middle school. This donation builds on our ongoing commitment to the community where we are headquartered globally – North Chicago – and our 6-year partnership to improve student success across the district.